Institute for Medical Genetics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
PLoS One. 2010 Feb 16;5(2):e9242. doi: 10.1371/journal.pone.0009242.
Mutations in the human gene MCPH1 cause primary microcephaly associated with a unique cellular phenotype with premature chromosome condensation (PCC) in early G2 phase and delayed decondensation post-mitosis (PCC syndrome). The gene encodes the BRCT-domain containing protein microcephalin/BRIT1. Apart from its role in the regulation of chromosome condensation, the protein is involved in the cellular response to DNA damage. We report here on the first mouse model of impaired Mcph1-function. The model was established based on an embryonic stem cell line from BayGenomics (RR0608) containing a gene trap in intron 12 of the Mcph1 gene deleting the C-terminal BRCT-domain of the protein. Although residual wild type allele can be detected by quantitative real-time PCR cell cultures generated from mouse tissues bearing the homozygous gene trap mutation display the cellular phenotype of misregulated chromosome condensation that is characteristic for the human disorder, confirming defective Mcph1 function due to the gene trap mutation. While surprisingly the DNA damage response (formation of repair foci, chromosomal breakage, and G2/M checkpoint function after irradiation) appears to be largely normal in cell cultures derived from Mcph1(gt/gt) mice, the overall survival rates of the Mcph1(gt/gt) animals are significantly reduced compared to wild type and heterozygous mice. However, we could not detect clear signs of premature malignant disease development due to the perturbed Mcph1 function. Moreover, the animals show no obvious physical phenotype and no reduced fertility. Body and brain size are within the range of wild type controls. Gene expression on RNA and protein level did not reveal any specific pattern of differentially regulated genes. To the best of our knowledge this represents the first mammalian transgenic model displaying a defect in mitotic chromosome condensation and is also the first mouse model for impaired Mcph1-function.
人类基因 MCPH1 的突变导致原发性小头畸形,其特征是在 G2 早期出现过早的染色体浓缩(PCC)和有丝分裂后延迟去浓缩(PCC 综合征)。该基因编码 BRCT 结构域包含蛋白 microcephalin/BRIT1。除了在调节染色体浓缩中的作用外,该蛋白还参与细胞对 DNA 损伤的反应。我们在这里报告了第一个 Mcph1 功能受损的小鼠模型。该模型是基于 BayGenomics(RR0608)的胚胎干细胞系建立的,该细胞系在 Mcph1 基因的内含子 12 中含有一个基因陷阱,该陷阱缺失了蛋白的 C 端 BRCT 结构域。尽管可以通过定量实时 PCR 检测到残留的野生型等位基因,但来自携带纯合基因陷阱突变的小鼠组织的细胞培养物显示出染色体浓缩失调的细胞表型,这是人类疾病的特征,证实了由于基因陷阱突变导致 Mcph1 功能缺陷。令人惊讶的是,来自 Mcph1(gt/gt) 小鼠的细胞培养物中的 DNA 损伤反应(修复焦点的形成、染色体断裂和照射后 G2/M 检查点功能)似乎基本正常,但 Mcph1(gt/gt) 动物的总存活率明显低于野生型和杂合型小鼠。然而,由于 Mcph1 功能失调,我们无法检测到明显的早期恶性疾病发展迹象。此外,这些动物没有明显的身体表型和生育力下降。身体和大脑大小都在野生型对照的范围内。RNA 和蛋白质水平的基因表达没有显示任何差异调节基因的特定模式。据我们所知,这是第一个显示有丝分裂染色体浓缩缺陷的哺乳动物转基因模型,也是第一个 Mcph1 功能受损的小鼠模型。